265 Watline Avenue
Mississauga, ON L4Z 1P3
Canada
905 361 8910
https://www.microbix.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees:
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Cameron L. Groome | President, CEO & Director | 416.65k | N/A | N/A |
Mr. James S. Currie | Chief Financial Officer | 266.51k | N/A | N/A |
Dr. Kenneth Hughes Ph.D. | Chief Operating Officer | 266.57k | N/A | N/A |
Dr. Mark Luscher Ph.D. | Senior Vice President of Scientific Affairs | 249.29k | N/A | N/A |
Mr. Philip Casselli | Senior Vice President of Sales, Business Development & Marketing | 265.1k | N/A | N/A |
Mr. Christopher B. Lobb | Compliance Officer, General Counsel & Secretary | N/A | N/A | N/A |
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
Microbix Biosystems Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.